Related references
Note: Only part of the references are listed.Increased levels of procoagulant tissue factor-bearing microparticles within the occluded coronary artery of patients with ST-segment elevation myocardial infarction: Role of endothelial damage and leukocyte activation
Olivier Morel et al.
ATHEROSCLEROSIS (2009)
Expression, activation, and function of integrin αMβ2 (Mac-1) on neutrophil-derived microparticles
Elzbieta Pluskota et al.
BLOOD (2008)
Circulating platelet-derived microparticles are associated with atherothrombotic events - A marker for vulnerable blood
Masashi Namba et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2007)
Circulating leukocyte-derived microparticles predict subclinical atherosclerosis burden in asymptomatic subjects
Gilles Chironi et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2006)
Benefit of a 600-mg loading dose of clopidogrel on platelet reactivity and clinical outcomes in patients with non-ST-segment elevation acute coronary syndrome undergoing coronary stenting
Thomas Cuisset et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2006)
Endothelial microparticles correlate with high-risk angiographic lesions in acute coronary syndromes
L Bernal-Mizrachi et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2004)
Activated polymorphonuclear neutrophils disseminate anti-inflammatory microparticles by ectocytosis
O Gasser et al.
BLOOD (2004)
Accumulation of tissue factor into developing thrombi in vivo is dependent upon microparticle P-selectin glycoprotein ligand 1 and platelet P-selectin
S Falati et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2003)
Elevated levels of shed membrane microparticles with procoagulant potential in the peripheral circulating blood of patients with acute coronary syndromes
Z Mallat et al.
CIRCULATION (2000)
Share Paper
